Chemiexcited Photodynamic Therapy Integrated in Polymeric Nanoparticles Capable of MRI Against Atherosclerosis
Dan Mu,Xin Wang,Huiting Wang,Xuan Sun,Qing Dai,Pin Lv,Renyuan Liu,Yu Qi,Jun Xie,Biao Xu,Bing Zhang
DOI: https://doi.org/10.2147/ijn.s355790
IF: 7.033
2022-05-21
International Journal of Nanomedicine
Abstract:Dan Mu, 1, &ast Xin Wang, 1, &ast Huiting Wang, 1 Xuan Sun, 2 Qing Dai, 2 Pin Lv, 1 Renyuan Liu, 1 Yu Qi, 2 Jun Xie, 2 Biao Xu, 2, 3 Bing Zhang 1, 4 1 Department of Radiology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, People's Republic of China; 2 Department of Cardiology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, People's Republic of China; 3 State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, 210023, People's Republic of China; 4 Institute of Brain Science, Nanjing University, Nanjing, Jiangsu, 210008, People's Republic of China &astThese authors contributed equally to this work Correspondence: Biao Xu; Bing Zhang, Email ; Background: Photodynamic therapy (PDT) has achieved continued success in the treatment of tumors, but its progress in the treatment of atherosclerosis has been limited, mainly due to the low tissue-penetration ability of the excitation light for photosensitizers. Methods: In this study, we designed a chemiexcited system producing singlet oxygen in an attempt to apply PDT for the treatment of atherosclerosis without the irradiation of external light. The system designed was polymeric nanoparticles (NPs) equipped with chemical fuel and photosensitizers, cross-linked with an Fe 3+ –catechol complex for stabilization and magnetic resonance imaging (MRI). Results: The system (FeCNPs for short) accumulated effectively in plaques, providing persistent and enhanced T 1 -weighted contrast ability. FeCNPs also prevented progression of atherosclerosis via macrophage elimination, and obviously reduced plaque size and thickness revealed by T 1 -weighted MRI. Expression of CD68, MCP1, and TNFα was significantly reduced after treatment. However, low doses of FeCNPs exhibited better therapeutic efficacy than high doses. Furthermore, low-dose FeCNPs exhibited effective macrophage elimination in aortic arches and abdominal aortae, but inefficiency in the thoracic aorta, aortic hiatus, and aorta–iliac bifurcation. Conclusion: This study provides the first example of a combination of MRI and chemiexcited PDT for atherosclerosis, evidencing the effectiveness of PDT and providing significant pointers for developing nanotherapy on atherosclerosis. Keywords: photodynamic therapy, atherosclerosis, chemi-excited, macrophages, MRI Photodynamic therapy (PDT) is an emerging noninvasive approach for tumor therapy. 1–3 Its functioning requires three elements: photosensitizers (PSs), light of appropriate wavelength to activate the PSs, and tissue oxygen. Due to its distinct advantages, PDT has been explored for management of atherosclerosis since last century. 4,5 With the development of PDT and deep understanding of atherosclerosis, positive results have been achieved, including eradicating diet-induced atheromatous plaques, 6 inhibiting the development of intimal hyperplasia, 7 and selectively eliminating macrophages. 8 However, negative results have also been reported. 9 It should be pointed out that many factors affect the evaluation of PDT in atherosclerosis, eg, types of PSs and their accumulation in plaques, the wavelength of excitation light, and experimental animal models. Recently, different types of photodynamic nanosystems have been fabricated, including polymeric micelles or nanoparticles (NPs), 10,11 upconversion NPs, 12,13 selenium NPs, 14 and liposomes. 15 All these reports focused on the clearance of macrophages via PDT, because macrophages have evidenced its vital role in the progression of atherosclerosis. 16–18 However, all these studies were conducted in vitro, with none proceeding to animal models. Caused by the strong light absorption and scattering properties of soft tissue, blood, and skin, the penetration depth of near-infrared (NIR) light is only a few millimeters, which fails to meet the requirement of the treatment of atherosclerosis. 19 That, we believe, is why recent trials of PDT on atherosclerosis have mostly stayed in cell experiments. Therefore, excitation light extensively restricts the application of PDT, especially in atherosclerosis. Apart for developing new types of PSs, two approaches have been used to overcome this drawback. One is to use an optical fiber catheter inserted into the aorta to excite the PSs. 20 Depending on the catheter, PSs or drugs can be affixed to its -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology